Company
Faron Pharmaceuticals Limited
LON:FARN
Faron Pharmaceuticals is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. The company’s lead asset bexmarilimab is currently being investigated in Phase I/II clinical trial as a potential therapy for patients with hematological cancers in combination with other standard treatments.
418 stories · page 5 of 21
Faron Pharmaceuticals focused on fighting cancers via novel immunotherapies
Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours